{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-060919","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2021-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.371309+00:00","generated_at":"2026-06-27T23:09:07.435068+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Achieve Life Sciences enters $15M contingent convertible debt agreement with SVB","bullets":["$15M initial term loan from SVB and SVB Innovation Credit Fund VIII; up to $10M additional subject to approval.","Convertible at $9.34/share; mandatory conversion if stock closes at $24+ for 30 consecutive trading days.","Interest: floating (prime−1%, floor 2.25%) cash + 7% PIK compounded monthly.","Maturity Dec 22, 2023, extendable to Dec 22, 2024 upon mutual agreement; prepayment penalties apply."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-060919","json":"https://secwatch.observer/filing/0001564590-21-060919.json","markdown":"https://secwatch.observer/filing/0001564590-21-060919.md","text":"https://secwatch.observer/filing/0001564590-21-060919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000156459021060919/0001564590-21-060919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000156459021060919/achv-8k_20211222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:09:07.435068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}